SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO), a clinical research organization (CRO) specializing in oncology, medical devices, dermatology and nephrology, today announced financial results for the three and six months ended June 30, 2007.
